AGR2 and adenocarcinoma: AGR2 (anterior gradient 2) is a well-known oncogenic promoter that is generally recognized as a secreted protein that is overexpressed in a variety of adenocarcinomas, including breast, prostate, pancreatic, gastrointestinal and urothelial tumors (11, 26–28).